Banner

Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children

Pediatric Nephrology • 2010
العودة
معلومات البحث
المؤلفون Abdulsamea S1, Anderson P, Biassoni L, Brennan E, McLaren CA, Marks SD, Roebuck DJ, Selim S, Tullus K
الكلمات المفتاحية Not Available
المجلة العلمية Pediatric Nephrology
الناشر Springer Berlin Heidelberg
المجلد 25
العدد 2
الصفحات 317-22
publication.type International
رابط البحث Open Link
المواد المرفقة Not Available
الملخص
We studied the ability of pre- and postcaptopril renal scintigraphy to predict renovascular disease (RVD) in children. Retrospective review of medical notes and radiology reports of all hypertensive children who had had both pre- and postcaptopril renal scintigraphy with [(99m)Tc] dimercaptosuccinic acid (DMSA) and/or [(99m)Tc] mercaptoacetyltriglycine (MAG3) and digital subtraction angiography (DSA). 81 children aged 1-18 (median 10) years were studied with 62% (51) having a diagnosis of RVD. Main renal artery disease, intrarenal disease, and both main and intrarenal artery disease were present in 25, 14, and 12 patients respectively. The isotope study accurately diagnosed RVD, confirmed by DSA, in 47% (24 of 51) children, with eight false positive studies. The sensitivity, specificity, and positive and negative predictive values of the isotope study to predict RVD were 48%, 73%, 76%, and 51%, respectively. Pre- and postcaptopril renal scintigraphy was unable to predict RVD in children